PR Newswire (Mon, 7:02AM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
279 people get RXII.OB articles and Market Currents by email alert.
Get email alerts on RXII.OB »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Marketwire (May 15, 2013)
-
Business Wire (Apr 30, 2013)
-
Business Wire (Apr 29, 2013)
-
Business Wire (Apr 22, 2013)
-
Business Wire (Mar 29, 2013)
-
Business Wire (Mar 12, 2013)
-
Business Wire (Mar 7, 2013)
-
Business Wire (Mar 7, 2013)
-
Business Wire (Feb 19, 2013)
To learn more about Seeking Alpha Pro, click here.
There are no Focus articles on RXII.OB.
There are no Transcripts on RXII.OB.
-
PR Newswire (Mon, 7:02AM)
-
Marketwire (May 15, 2013)
-
Business Wire (Apr 30, 2013)
-
Business Wire (Apr 29, 2013)
-
Business Wire (Apr 22, 2013)
-
Business Wire (Mar 29, 2013)
-
Business Wire (Mar 12, 2013)
-
Business Wire (Mar 7, 2013)
-
Business Wire (Mar 7, 2013)
-
Business Wire (Feb 19, 2013)
RXII.OB vs. ETF Alternatives
Company Description
Currently, there's no company description for RXII.OB.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Thursday, March 7, 8:58 AM RXi Pharmaceuticals (RXII.OB) raises a gross $16.4M in a private placement led by OPKO Health (OPK) and Frost Gamma Investments Trust, which is controlled by Teva Chairman Phillip Frost. RXi issues 113M shares at $0.145 each, the same as yesterday's closing price. The firm will also acquire substantially all of OPKO's RNAi-related assets in exchange for 50M shares, as well as milestone and royalty payments. Comment! [Healthcare]
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.
